Literature DB >> 18257395

Managing liver metastases with conformal radiation therapy.

Erkan Topkan1, Huseyin Cem Onal, Melek Nur Yavuz.   

Abstract

A subgroup of liver metastases, especially those emanating from colorectal carcinoma, may be cured. Surgical excision is accepted as the mainstay of treatment for these malignancies; unfortunately, however, the majority of patients presents with advanced unresectable hepatic involvement and have no standard treatment option available. Radiation therapy (RT) has not played a significant role in managing liver metastases, because the liver has little tolerance to radiation. In patients with good hepatic function, however, very-high-dose RT may be used safely and effectively if a small volume of the liver (< 25%) is irradiated. In particular, RT, and especially three-dimensional conformal RT (3D-CRT), may be used to manage medically unfit patients or those with an unresectable metastatic liver lesion. This review discusses existing literature on use of various types of RT, including whole-liver irradiation, partial hepatic irradiation with 3D-CRT, and hypofractionated high-dose irradiation with stereotactic body RT, and future directions for this treatment modality.

Entities:  

Mesh:

Year:  2008        PMID: 18257395

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  5 in total

1.  [Meaningfullness and duration of palliative chemotherapy with regard to the quality of life of palliative patients].

Authors:  Heidemarie Seemann; Johannes G Meran
Journal:  Wien Med Wochenschr       Date:  2010-02

2.  Hypofractionated radiotherapy with tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions.

Authors:  Jong Hoon Lee; Joo Hwan Lee; Hong Seok Jang; Hyo Chun Lee; Jung Won Lee; Dae Gyu Kang; Byoung Yong Shim; Bong-Hyeon Kye; Hyung Jin Kim; Hyeon-Min Cho; Young Jin Suh; Sung Hwan Kim
Journal:  Clin Exp Metastasis       Date:  2013-02-06       Impact factor: 5.150

3.  Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.

Authors:  Andrea Cercek; Taryn M Boucher; Jill S Gluskin; Ariel Aguiló; Joanne F Chou; Louise C Connell; Marinela Capanu; Diane Reidy-Lagunes; Michael D'Angelica; Nancy E Kemeny
Journal:  J Surg Oncol       Date:  2016-08-26       Impact factor: 3.454

4.  CT- versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison.

Authors:  Cem Parlak; Erkan Topkan; Serhat Sonmez; Cem Onal; Mehmet Reyhan
Journal:  Jpn J Radiol       Date:  2012-06-30       Impact factor: 2.374

Review 5.  Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.

Authors:  Mohammed Yahia Almaghrabi; Stéphane Supiot; Francois Paris; Marc-André Mahé; Emmanuel Rio
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.